Chad Allen Johnson is Director of LUMOS PHARMA, INC.. Currently has a direct ownership of 0 shares of LUMO, which is worth approximately $0. The most recent transaction as insider was on Dec 12, 2024, when has been sold 1,076 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

CHAD ALLEN JOHNSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2024
SELL
Sale (or disposition) back to the issuer
-
1,076 Reduced 100.0%
0 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
367 Added 25.43%
1,076 Common Stock
CAJ

Chad Allen Johnson

Director
Austin, TX

Track Institutional and Insider Activities on LUMO

Follow LUMOS PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO